Teladoc Health (NYSE:TDOC) Reaches New 12-Month Low – Here’s Why

Teladoc Health, Inc. (NYSE:TDOC)’s stock price hit a new 52-week low on Friday . The company traded as low as $6.34 and last traded at $6.3250, with a volume of 4744722 shares trading hands. The stock had previously closed at $6.53.

Analyst Ratings Changes

TDOC has been the topic of several recent analyst reports. Bank of America reduced their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. BMO Capital Markets began coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target on the stock. Citigroup lowered their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Friday, January 9th. Evercore ISI dropped their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research note on Thursday, October 30th. Finally, Barclays initiated coverage on Teladoc Health in a research note on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 target price for the company. Five investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $9.50.

Teladoc Health Trading Down 4.1%

The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71. The business’s fifty day moving average is $7.29 and its 200 day moving average is $7.77. The firm has a market capitalization of $1.11 billion, a price-to-earnings ratio of -4.89 and a beta of 2.04.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The firm had revenue of $626.44 million during the quarter, compared to analyst estimates of $625.66 million. During the same period in the prior year, the business earned ($0.19) EPS. The company’s revenue for the quarter was down 2.2% compared to the same quarter last year. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 5,720 shares of Teladoc Health stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $42,842.80. Following the sale, the insider owned 80,732 shares of the company’s stock, valued at approximately $604,682.68. This trade represents a 6.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Charles Divita III sold 17,138 shares of the business’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $7.63, for a total value of $130,762.94. Following the completion of the sale, the chief executive officer owned 201,036 shares in the company, valued at $1,533,904.68. The trade was a 7.86% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 33,288 shares of company stock valued at $251,684 in the last ninety days. Corporate insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Y Intercept Hong Kong Ltd bought a new stake in Teladoc Health during the second quarter worth $2,722,000. Farther Finance Advisors LLC increased its stake in shares of Teladoc Health by 424.5% during the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock worth $87,000 after purchasing an additional 8,061 shares during the last quarter. Ameritas Advisory Services LLC bought a new stake in shares of Teladoc Health in the 2nd quarter valued at about $78,000. Wealth Management Associates Inc. acquired a new stake in Teladoc Health in the 2nd quarter valued at about $509,000. Finally, Strs Ohio bought a new position in Teladoc Health during the first quarter worth about $349,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.